Welcome to LookChem.com Sign In|Join Free

CAS

  • or

181289-58-7

Post Buying Request

181289-58-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

181289-58-7 Usage

Description

(+)-TRAMADOL, a synthetic opioid analgesic, is utilized for the management of moderate to severe pain. It functions by binding to opioid receptors in the brain and spinal cord, which diminishes the perception of pain. Additionally, it inhibits the reuptake of serotonin and norepinephrine, augmenting its analgesic properties. Although it shares a similar mechanism of action with morphine, (+)-TRAMADOL is deemed to have a lower potential for abuse and dependence. However, it is not devoid of risks, as it can still lead to addiction and respiratory depression, necessitating cautious use, particularly among individuals with a history of substance abuse or mental health disorders. Common side effects associated with (+)-TRAMADOL include dizziness, nausea, constipation, and drowsiness.

Uses

Used in Pharmaceutical Industry:
(+)-TRAMADOL is used as an analgesic agent for the treatment of moderate to severe pain. It is effective due to its action on opioid receptors and its ability to inhibit the reuptake of serotonin and norepinephrine, providing enhanced pain relief.
Used in Pain Management:
(+)-TRAMADOL is used as a pain management medication for patients suffering from various types of moderate to severe pain, offering an alternative to other opioids with a lower potential for abuse and dependence.
Used in Medical Treatments:
(+)-TRAMADOL is utilized in medical treatments where pain control is necessary, such as post-operative pain, chronic pain conditions, and neuropathic pain, while being cautious of its potential side effects and risks of addiction.

Check Digit Verification of cas no

The CAS Registry Mumber 181289-58-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,1,2,8 and 9 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 181289-58:
(8*1)+(7*8)+(6*1)+(5*2)+(4*8)+(3*9)+(2*5)+(1*8)=157
157 % 10 = 7
So 181289-58-7 is a valid CAS Registry Number.

181289-58-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (+)-TRAMADOL

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:181289-58-7 SDS

181289-58-7Relevant articles and documents

Continuous-Flow Synthesis of Tramadol from Cyclohexanone

Monos, Timothy M.,Jaworski, Jonathan N.,Stephens, John C.,Jamison, Timothy F.

, p. 1888 - 1893 (2020/11/24)

A multioperation, continuous-flow platform for the synthesis of tramadol, ranging from gram to decagram quantities, is described. The platform is segmented into two halves allowing for a single operator to modulate between preparation of the intermediate by Mannich addition or complete the fully concatenated synthesis. All purification operations are incorporated in-line for the Mannich reaction. 'Flash' reactivity between meta-methoxyphenyl magnesium bromide and the Mannich product was controlled with a static helical mixer and tested with a combination of flow and batch-based and factorial evaluations. These efforts culminated in a rapid production rate of tramadol (13.7 g°h -1) sustained over 56 reactor volumes. A comparison of process metrics including E-Factor, production rate, and space-time yield are used to contextualize the developed platform with respect to established engineering and synthetic methods for making tramadol.

Simultaneous chiral separation of tramadol and methadone in tablets, human urine, and plasma by capillary electrophoresis using maltodextrin as the chiral selector

Naghdi, Elahe,Fakhari, Ali Reza

, p. 1161 - 1168 (2018/09/06)

The stereoselective analysis and separation of racemic drugs play an important role in pharmaceutical industry to eliminate the unwanted isomer and find the right therapeutic control for the patient. Present study suggests a maltodextrin-modified capillary electrophoresis method for a single‐run chiral separation of two closely similar opiate pain relief drugs: tramadol (TRA) and methadone (MET). The best separation method possible for the both enantiomers was achieved on an uncoated fused‐silica capillary at 25°C using 100 mM phosphate buffer (pH 8.0) containing 20% (w v?1) maltodextrin with dextrose equivalent of 4–7 and an applied voltage of 16 kV. Under optimal conditions, the baseline resolution of TRA and MET enantiomers was obtained in less than 12 minutes. The relative standard deviations (n = 3) of 20 μg mL?1 TRA and MET were 2.28% and 3.77%, respectively. The detection limits were found to be 2 μg mL?1 for TRA and 1.5 μg mL?1 for MET. This method was successfully applied to the measurement of drugs concentration in their tablets, urine, and plasma samples.

Optimization of throughput in semipreparative chiral liquid chromatography using stacked injection

Taheri, Mohammadreza,Fotovati, Mohsen,Hosseini, Seyed-Kiumars,Ghassempour, Alireza

, p. 579 - 588 (2017/09/29)

An interesting mode of chromatography for preparation of pure enantiomers from pure samples is the method of stacked injection as a pseudocontinuous procedure. Maximum throughput and minimal production costs can be achieved by the use of total chiral column length in this mode of chromatography. To maximize sample loading, often touching bands of the two enantiomers is automatically achieved. Conventional equations show direct correlation between touching-band loadability and the selectivity factor of two enantiomers. The important question for one who wants to obtain the highest throughput is “How to optimize different factors including selectivity, resolution, run time, and loading of the sample in order to save time without missing the touching-band resolution?” To answer this question, tramadol and propranolol were separated on cellulose 3,5-dimethyl phenyl carbamate, as two pure racemic mixtures with low and high solubilities in mobile phase, respectively. The mobile phase composition consisted of n-hexane solvent with alcohol modifier and diethylamine as the additive. A response surface methodology based on central composite design was used to optimize separation factors against the main responses. According to the stacked injection properties, two processes were investigated for maximizing throughput: one with a poorly soluble and another with a highly soluble racemic mixture. For each case, different optimization possibilities were inspected. It was revealed that resolution is a crucial response for separations of this kind. Peak area and run time are two critical parameters in optimization of stacked injection for binary mixtures which have low solubility in the mobile phase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 181289-58-7